Relay Therapeutics retreats on planned equity offering

Relay Therapeutics

10/09/2024 15:05

** Shares of Relay Therapeutics  RLAY.O  down 10% at $8.56
early Tues as co plans equity raise
    ** RLAY shares on Mon surged 52% to close at $9.51 after co
said its breast cancer treatment cut disease progression in
early-stage trial
    ** Co after the bell Mon launched $200 mln stock offering
    ** Goldman Sachs, TD Cowen, Stifel and BofA are jt
bookrunners
    ** Co has 133.9 mln shares outstanding
    ** With move on the session, shares down 22% YTD following
26% decline in 2023

 (Lance Tupper is a Reuters market analyst. The views expressed
are his own)
 ((lance.tupper@thomsonreuters.com
lance.tupper@tr.com 1-646-279-6380))